Cargando…

In-Silico Molecular Modeling Studies to Identify Novel Potential Inhibitors of HPV E6 Protein

The etiological agent of some anogenital tract cancers is infection with the high-risk human papillomavirus (HPV). Currently, prophylactic vaccines against HPV have been validated, but the presence of drug treatment directed against the infection and its oncogenic effects remain essential. Among the...

Descripción completa

Detalles Bibliográficos
Autores principales: Soumia, Moujane, Hajji, Halima, El Mzibri, Mohamed, Younes, Filali Zegzouti, Mohammed, Bouachrine, Mohamed, Benlyas, Benaissa, Moualij
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505724/
https://www.ncbi.nlm.nih.gov/pubmed/36146532
http://dx.doi.org/10.3390/vaccines10091452
_version_ 1784796544470351872
author Soumia, Moujane
Hajji, Halima
El Mzibri, Mohamed
Younes, Filali Zegzouti
Mohammed, Bouachrine
Mohamed, Benlyas
Benaissa, Moualij
author_facet Soumia, Moujane
Hajji, Halima
El Mzibri, Mohamed
Younes, Filali Zegzouti
Mohammed, Bouachrine
Mohamed, Benlyas
Benaissa, Moualij
author_sort Soumia, Moujane
collection PubMed
description The etiological agent of some anogenital tract cancers is infection with the high-risk human papillomavirus (HPV). Currently, prophylactic vaccines against HPV have been validated, but the presence of drug treatment directed against the infection and its oncogenic effects remain essential. Among the best drug targets, viral oncoprotein E6 has been identified as a key factor in cell immortalization and tumor progression in HPV-positive cells. E6, through interaction with the cellular ubiquitin ligase E6AP, can promote the degradation of p53, a tumor suppressor protein. Therefore, suppression of the creation of the E6-E6AP complex is one of the essential strategies to inhibit the survival and proliferation of infected cells. In the present study, we proposed an in-silico approach for the discovery of small molecules with inhibitory activity on the E6-E6AP interaction. The first three compounds (F0679-0355, F33774-0275, and F3345-0326) were selected on the basis of virtual screening and prediction of the molecules’ ADMET properties and docking with E6 protein, these molecules were selected for further study by investigating their stability in the E6 complex and their inhibitory effect on the E6-E6AP interaction by molecular dynamics (MD) simulation. The identified molecules thus represent a good starting point for the development of anti-HPV drugs.
format Online
Article
Text
id pubmed-9505724
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95057242022-09-24 In-Silico Molecular Modeling Studies to Identify Novel Potential Inhibitors of HPV E6 Protein Soumia, Moujane Hajji, Halima El Mzibri, Mohamed Younes, Filali Zegzouti Mohammed, Bouachrine Mohamed, Benlyas Benaissa, Moualij Vaccines (Basel) Article The etiological agent of some anogenital tract cancers is infection with the high-risk human papillomavirus (HPV). Currently, prophylactic vaccines against HPV have been validated, but the presence of drug treatment directed against the infection and its oncogenic effects remain essential. Among the best drug targets, viral oncoprotein E6 has been identified as a key factor in cell immortalization and tumor progression in HPV-positive cells. E6, through interaction with the cellular ubiquitin ligase E6AP, can promote the degradation of p53, a tumor suppressor protein. Therefore, suppression of the creation of the E6-E6AP complex is one of the essential strategies to inhibit the survival and proliferation of infected cells. In the present study, we proposed an in-silico approach for the discovery of small molecules with inhibitory activity on the E6-E6AP interaction. The first three compounds (F0679-0355, F33774-0275, and F3345-0326) were selected on the basis of virtual screening and prediction of the molecules’ ADMET properties and docking with E6 protein, these molecules were selected for further study by investigating their stability in the E6 complex and their inhibitory effect on the E6-E6AP interaction by molecular dynamics (MD) simulation. The identified molecules thus represent a good starting point for the development of anti-HPV drugs. MDPI 2022-09-02 /pmc/articles/PMC9505724/ /pubmed/36146532 http://dx.doi.org/10.3390/vaccines10091452 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Soumia, Moujane
Hajji, Halima
El Mzibri, Mohamed
Younes, Filali Zegzouti
Mohammed, Bouachrine
Mohamed, Benlyas
Benaissa, Moualij
In-Silico Molecular Modeling Studies to Identify Novel Potential Inhibitors of HPV E6 Protein
title In-Silico Molecular Modeling Studies to Identify Novel Potential Inhibitors of HPV E6 Protein
title_full In-Silico Molecular Modeling Studies to Identify Novel Potential Inhibitors of HPV E6 Protein
title_fullStr In-Silico Molecular Modeling Studies to Identify Novel Potential Inhibitors of HPV E6 Protein
title_full_unstemmed In-Silico Molecular Modeling Studies to Identify Novel Potential Inhibitors of HPV E6 Protein
title_short In-Silico Molecular Modeling Studies to Identify Novel Potential Inhibitors of HPV E6 Protein
title_sort in-silico molecular modeling studies to identify novel potential inhibitors of hpv e6 protein
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505724/
https://www.ncbi.nlm.nih.gov/pubmed/36146532
http://dx.doi.org/10.3390/vaccines10091452
work_keys_str_mv AT soumiamoujane insilicomolecularmodelingstudiestoidentifynovelpotentialinhibitorsofhpve6protein
AT hajjihalima insilicomolecularmodelingstudiestoidentifynovelpotentialinhibitorsofhpve6protein
AT elmzibrimohamed insilicomolecularmodelingstudiestoidentifynovelpotentialinhibitorsofhpve6protein
AT younesfilalizegzouti insilicomolecularmodelingstudiestoidentifynovelpotentialinhibitorsofhpve6protein
AT mohammedbouachrine insilicomolecularmodelingstudiestoidentifynovelpotentialinhibitorsofhpve6protein
AT mohamedbenlyas insilicomolecularmodelingstudiestoidentifynovelpotentialinhibitorsofhpve6protein
AT benaissamoualij insilicomolecularmodelingstudiestoidentifynovelpotentialinhibitorsofhpve6protein